FSA earmarks Keydata-style funds as 'unsuitable for mainstream'

Laura Miller
clock •

The FSA has earmarked Keydata-style traded life policies as a product "generally unsuitable for the mainstream retail market".

Traded life policy investments, the underlying assets of the funds marketed by failed investment firm Keydata, are only suitable for "sophisticated customers capable of fully understanding the way in which the product works and the likelihood of it failing," the FSA states today. The asset class features on an initial list of products, published this morning in an FSA discussion paper, which the watchdog says have already caused problems for consumers, and would likely be deemed unsuitable for mainstream investors in the future. An new FSA-rated list of non-mainstream products is one ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Why managing retirement risk matters more than predicting markets

Why managing retirement risk matters more than predicting markets

'Helping clients understand, prepare for and navigate uncertainty'

Andy Brown
clock 12 November 2026 • 4 min read
Solving private markets risks 'almost mission impossible'

Solving private markets risks 'almost mission impossible'

Julius Baer’s Cyril Demaria-Bengochea speaks to Professional Adviser

Sophia Panayi
clock 12 November 2026 • 3 min read
Anthropic bankers preparing to increase IPO valuation to $1.5trn – reports

Anthropic bankers preparing to increase IPO valuation to $1.5trn – reports

Draft prospectus filed on Tuesday

Jack Roach
clock 11 November 2026 • 2 min read